Skip to main content
. 2020 Jul 14;12:5749–5758. doi: 10.2147/CMAR.S249686

Figure 5.

Figure 5

miR-331-3p repressed tumor cell proliferation, metastasis, invasion by targeting MLLT10 in NSCLC. (A) Cell viabilities were detected in A549 cells transfected with LV-NC, LV-anti-miR-331-3p, or LV-anti-miR-331-3p+shMLLT10 from Day1 to Day5 with the help of CCK-8 assay. (B) Cell viabilities were detected in H1650 cells transfected with LV-NC, LV-miR-331-3p, or LV-miR-331-3p+LV-MLLT10 from Day1 to Day5 with the help of CCK-8 assay.(C) The migration and invasion cell numbers of A549 cells transfected with LV-NC, LV-anti-miR-331-3p, or LV-anti-miR-331-3p+shMLLT10 using Transwell assay.(D) The migration and invasion cell numbers of H1650 cells transfected with LV-NC, LV-miR-331-3p, or LV-miR-331-3p+LV-MLLT10 using Transwell assay. All quantitative values were the average of three independent experiments. *P<0.05,**P<0.01.